Health | Carolyn Y Johnson, The Washington Post | Tuesday November 20, 2018
After a year of treatment with an experimental drug made by Aimmune Therapeutics, 67% of children and teenagers with peanut allergies were able to safely ingest the equivalent of at least two peanuts.
www.ndtv.com